Back to Trades
Patni Rajiv
DirectorCIK 0001616200
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, Patni Rajiv, Director, has disclosed $34.2K in transactions — all concentrated in BioXcel Therapeutics, Inc. (BTAI). Data is sourced from official SEC Form 3, 4, and 5 filings.